Cellective Dx Overview
- Year Founded
-
2005

- Status
-
Acquired/Merged
- Employees
-
8

- Latest Deal Type
-
M&A
Cellective Dx General Information
Description
Developer of diagnostic, monitoring and molecular analytical tools for cancer. The company's diagnostic tools are based on the analysis of CTCs from patient's blood. Its technologies combine microfluids, flow dynamics, cell biology, molecular biology, biochemistry and surface chemistry to capture and analyze rare CTCs in blood.
Contact Information
Website
www.cellpointdiagnostics.comCorporate Office
- 265 North Whisman Road
- Mountain View, CA 94043
- United States
Corporate Office
- 265 North Whisman Road
- Mountain View, CA 94043
- United States
Cellective Dx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Merger/Acquisition | 31-May-2009 | Completed | Startup | |||
5. Early Stage VC (Series B) | 13-May-2009 | Completed | Generating Revenue | |||
4. Early Stage VC | 19-Aug-2008 | Completed | Startup | |||
3. Early Stage VC (Series A1) | 13-Sep-2007 | Completed | Startup | |||
2. Early Stage VC (Series A) | 16-Sep-2006 | $8.5M | $8.5M | Completed | Startup | |
1. Grant | 01-Jan-2006 | $142K | Completed | Startup |
Cellective Dx Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series A1 | ||||||||
Series A | 9,806,039 | $0.001000 | $0.07 | $0.92 | $0.92 | 1x | $0.92 | 21.02% |
Cellective Dx Patents
Cellective Dx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20090233324-A1 | Methods for diagnosing cancer using samples collected from a central vein location or an arterial location | Inactive | 11-Mar-2008 | ||
US-20090162941-A1 | Methods and devices, including stoppers comprising an internal recess with particular hydrophilicity characteristics, for limiting air ingestion during sample extraction | Inactive | 21-Dec-2007 | ||
EP-2024512-A2 | Methods for the diagnosis of fetal abnormalities | Inactive | 14-Jun-2006 | ||
EP-2024512-A4 | Methods for the diagnosis of fetal abnormalities | Inactive | 14-Jun-2006 | ||
US-20070026415-A1 | Devices and methods for enrichment and alteration of circulating tumor cells and other particles | Inactive | 29-Jul-2005 | B01L3/502746 |
Cellective Dx Signals
Cellective Dx Former Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Mohr Davidow Ventures | Venture Capital | Minority | ||
Northgate Capital | Fund of Funds | Minority | ||
Northport Investments | PE/Buyout | Minority | ||
Paperboy Ventures | Merchant Banking Firm | Minority | ||
U.S. Department of Health and Human Services | Government |
Cellective Dx FAQs
-
When was Cellective Dx founded?
Cellective Dx was founded in 2005.
-
Where is Cellective Dx headquartered?
Cellective Dx is headquartered in Mountain View, CA.
-
What is the size of Cellective Dx?
Cellective Dx has 8 total employees.
-
What industry is Cellective Dx in?
Cellective Dx’s primary industry is Diagnostic Equipment.
-
Is Cellective Dx a private or public company?
Cellective Dx is a Private company.
-
What is Cellective Dx’s current revenue?
The current revenue for Cellective Dx is
. -
How much funding has Cellective Dx raised over time?
Cellective Dx has raised $29.8M.
-
Who are Cellective Dx’s investors?
Mohr Davidow Ventures, Northgate Capital, Northport Investments, Paperboy Ventures, and U.S. Department of Health and Human Services have invested in Cellective Dx.
-
When was Cellective Dx acquired?
Cellective Dx was acquired on 31-May-2009.
-
Who acquired Cellective Dx?
Cellective Dx was acquired by On-Q-ity.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »